Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Past Earnings Performance
Past criteria checks 0/6
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's earnings have been declining at an average annual rate of -4.4%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 14.2% per year. Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's return on equity is 2.1%, and it has net margins of 0.5%.
Key information
-4.4%
Earnings growth rate
-14.1%
EPS growth rate
| Consumer Retailing Industry Growth | 12.8% |
| Revenue growth rate | 14.2% |
| Return on equity | 2.1% |
| Net Margin | 0.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.'s (SZSE:300937) P/S Is Still On The Mark Following 48% Share Price Bounce
Nov 12
Capital Allocation Trends At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Aren't Ideal
Sep 27Returns On Capital At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Paint A Concerning Picture
Jun 07Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's (SZSE:300937) Earnings Are Of Questionable Quality
Apr 17Revenue & Expenses Breakdown
How Sichuan Hezong Medicine Easy-to-buy Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 4,454 | 23 | 295 | 18 |
| 30 Jun 24 | 4,451 | 25 | 275 | 19 |
| 31 Mar 24 | 4,546 | 37 | 270 | 19 |
| 31 Dec 23 | 4,430 | 60 | 257 | 19 |
| 30 Sep 23 | 4,499 | 75 | 272 | 19 |
| 30 Jun 23 | 4,416 | 81 | 262 | 18 |
| 31 Mar 23 | 4,181 | 65 | 248 | 17 |
| 01 Jan 23 | 3,969 | 42 | 224 | 18 |
| 30 Sep 22 | 3,677 | 12 | 191 | 24 |
| 30 Jun 22 | 3,565 | 5 | 177 | 20 |
| 31 Mar 22 | 3,480 | 14 | 160 | 16 |
| 01 Jan 22 | 3,401 | 6 | 165 | 11 |
| 30 Sep 21 | 3,172 | 33 | 140 | 0 |
| 30 Jun 21 | 3,049 | 40 | 136 | 0 |
| 31 Mar 21 | 2,917 | 45 | 136 | 0 |
| 31 Dec 20 | 2,790 | 54 | 127 | 0 |
| 30 Sep 20 | 2,689 | 69 | 244 | 0 |
| 31 Dec 19 | 2,289 | 65 | 125 | 0 |
| 31 Dec 18 | 2,024 | 57 | 97 | 0 |
| 31 Dec 17 | 1,587 | 45 | 85 | 0 |
| 31 Dec 16 | 1,241 | 29 | 62 | 0 |
Quality Earnings: 300937 has a large one-off gain of CN¥8.7M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 300937's current net profit margins (0.5%) are lower than last year (1.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300937's earnings have declined by 4.4% per year over the past 5 years.
Accelerating Growth: 300937's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300937 had negative earnings growth (-69.1%) over the past year, making it difficult to compare to the Consumer Retailing industry average (6%).
Return on Equity
High ROE: 300937's Return on Equity (2.1%) is considered low.